{"answers":{"affected":"It affects 1 product.","exploited":"There is no known exploitation of CVE-2024-2274 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2024-2274 yet. Limit exposure of the affected software until one is available.","what":"CVE-2024-2274 is a low-severity cross-site scripting vulnerability in Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software, published on 8 Mar 2024. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link."},"fix_prompt":"Check this codebase for CVE-2024-2274 and fix it if it is affected.\n\nWhat it is: CVE-2024-2274 is a low-severity cross-site scripting vulnerability in Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software, published on 8 Mar 2024. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link.\nExploitation: There is no known exploitation of CVE-2024-2274 in the wild and no public exploit code.\n\nAffected product: Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2024-2274/ (Markdown: https://insights.sbomify.com/CVE-2024-2274/index.md)","id":"CVE-2024-2274","markdown":"https://insights.sbomify.com/CVE-2024-2274/index.md","name":"CVE-2024-2274","record":{"aliases":["GHSA-p75m-6rqr-7673"],"analysis":{"component_type":"web_application","fix_type":"no_fix_stated","impacts":["code_execution","account_takeover"],"network_reachable":"yes","non_default_config":false,"product_category":"Gynaecology consultation software","requires_auth":"high_privilege","summary":"Remote attackers can inject malicious scripts via the Title argument in the Prescription Dashboard, potentially compromising user sessions.","user_interaction":"required","vuln_class":"xss"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"VulDB","cpe":[{"product":"g-prescription_gynaecology_\\\u0026_obs_consultation","vendor":"bdtask"}],"cvss":{"score":2.4,"severity":"low","source":"cna","vector":"CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N","version":"3.1"},"cwes":[{"id":"CWE-79","name":"Improper Neutralization of Input During Web Page Generation"}],"description":"A vulnerability, which was classified as problematic, has been found in Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software 1.0. This issue affects some unknown processing of the file /Home/Index of the component Prescription Dashboard. The manipulation of the argument Title leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The associated identifier of this vulnerability is VDB-256043. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software Prescription Dashboard Index cross site scripting","id":"CVE-2024-2274","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"xss","year":"2024"},"n_packages":0,"n_references":3,"next":{"headline":"Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting","id":"CVE-2024-2275"},"packages":[],"prev":{"headline":"Cross-site scripting in Kadence Blocks — Page Builder Toolkit for Gutenberg Editor","id":"CVE-2024-2273"},"products":["G-Prescription Gynaecology \u0026 OBS Consultation Software"],"published":"2024-03-08","related":[{"cvss_score":4.3,"headline":"Cross-site request forgery in G-Prescription Gynaecology \u0026 OBS Consultation Software","id":"CVE-2024-2277","kev_date_added":null,"published":"2024-03-08"},{"cvss_score":2.4,"headline":"Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting","id":"CVE-2024-2275","kev_date_added":null,"published":"2024-03-08"},{"cvss_score":2.4,"headline":"Bdtask G-Prescription Gynaecology \u0026 OBS Consultation Software Edit Venue Page cross site scripting","id":"CVE-2024-2276","kev_date_added":null,"published":"2024-03-08"}],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"no","exploitation":"none","technical_impact":"partial"},"state":"PUBLISHED","updated":"2024-08-01","vendors":["Bdtask"]},"summary":"Remote attackers can inject malicious scripts via the Title argument in the Prescription Dashboard, potentially compromising user sessions.","url":"https://insights.sbomify.com/CVE-2024-2274/"}